HMLSF logo

Global X Marijuana Life Sciences Index ETF (HMLSF) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Global X Marijuana Life Sciences Index ETF (HMLSF) opera en el sector Financial Services, cotizado por última vez a $ con una capitalización de mercado de 0. Calificado con 44/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.

Ultimo analisis: 15 mar 2026
Puntuación de IA de 44/100

Global X Marijuana Life Sciences Index ETF (HMLSF) Perfil de Servicios Financieros

CEODavid Kunselman
Año de la oferta pública inicial (OPI)2017

Global X Marijuana Life Sciences Index ETF (HMLSF) provides investors with diversified exposure to North American publicly listed companies in the marijuana industry. The fund seeks to replicate the performance of the North American Marijuana Index, rebalancing quarterly to adapt to the rapidly evolving sector. It offers a way to participate in the marijuana market while mitigating risks associated with individual companies.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 15 mar 2026

Tesis de Inversión

HMLSF presents a targeted investment vehicle for those seeking exposure to the North American marijuana industry. With a market capitalization of $0.04 billion and a beta of 1.65, it reflects the volatility inherent in this emerging sector. The fund's quarterly rebalancing mechanism allows it to adapt to the evolving market dynamics, capturing potential growth opportunities as they arise. Key value drivers include the increasing legalization and acceptance of marijuana across North America, which could lead to increased market participation and higher valuations for companies within the index. However, investors should be aware of the risks associated with regulatory uncertainty and market fluctuations, which could impact the fund's performance. The absence of a dividend yield may deter some investors seeking regular income.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Market Cap of $0.04B indicates the fund's size and potential for growth within the marijuana sector.
  • Beta of 1.65 suggests higher volatility compared to the broader market, reflecting the speculative nature of the marijuana industry.
  • Quarterly rebalancing ensures the portfolio remains aligned with the North American Marijuana Index and captures emerging trends.
  • Diversified exposure to North American publicly listed companies within the marijuana industry reduces the risk associated with individual securities.
  • Absence of dividend yield may not appeal to income-focused investors.

Competidores y Pares

Fortalezas

  • Diversified exposure to the North American marijuana industry.
  • Quarterly rebalancing to adapt to market changes.
  • Replication of the North American Marijuana Index.
  • ETF structure provides liquidity and transparency.

Debilidades

  • High beta indicates significant volatility.
  • Absence of dividend yield may deter some investors.
  • Performance is dependent on the overall marijuana market.
  • Regulatory uncertainty in the marijuana industry.

Catalizadores

  • Ongoing: Increasing legalization of marijuana across North America is expected to drive market growth.
  • Ongoing: Growing acceptance of marijuana for medical and recreational use is fueling demand.
  • Upcoming: Potential regulatory changes could create new opportunities for companies in the marijuana industry.
  • Ongoing: Continued research into the pharmaceutical applications of marijuana may lead to new treatments and therapies.
  • Ongoing: Market expansion and the emergence of new products and services are expected to drive revenue growth.

Riesgos

  • Potential: Regulatory uncertainty and changes could negatively impact the marijuana industry.
  • Ongoing: Competition from other marijuana-focused ETFs could limit HMLSF's market share.
  • Potential: Market fluctuations and volatility could lead to significant losses for investors.
  • Potential: Negative public perception of marijuana could hinder market growth.
  • Ongoing: The fund's performance is dependent on the overall marijuana market, which is subject to various risks.

Oportunidades de crecimiento

  • Increased Legalization: The ongoing trend of marijuana legalization across North America presents a significant growth opportunity for HMLSF. As more states and countries legalize marijuana for medical or recreational use, the market size expands, leading to increased revenue and profitability for companies within the index. This trend is expected to continue over the next 5-10 years, driving demand for marijuana-related products and services and potentially boosting the fund's performance.
  • Market Expansion: The North American marijuana market is projected to experience substantial growth in the coming years. As the market matures, new products and services are expected to emerge, catering to a wider range of consumer preferences. This expansion could lead to increased investment in marijuana-related companies, benefiting HMLSF's portfolio. The fund's diversified exposure to the sector positions it to capture the upside from this market expansion.
  • Pharmaceutical Applications: The growing recognition of marijuana's potential pharmaceutical applications presents another growth opportunity. As research and development efforts yield new medical treatments and therapies based on marijuana-derived compounds, companies within the index could experience increased revenue and profitability. This could drive investor interest in HMLSF, as it provides exposure to companies at the forefront of this emerging field.
  • Mergers and Acquisitions: The marijuana industry is expected to undergo consolidation as companies seek to gain market share and achieve economies of scale. This could lead to mergers and acquisitions (M&A) activity, which could benefit HMLSF's portfolio. Companies that are acquired at a premium could generate significant returns for the fund, while the remaining companies could benefit from reduced competition and increased market power.
  • Global Expansion: While HMLSF focuses on North American companies, the global marijuana market is also experiencing growth. As more countries legalize marijuana, North American companies could expand their operations internationally, increasing their revenue and profitability. This could indirectly benefit HMLSF's portfolio, as it provides exposure to companies with global growth potential.

Oportunidades

  • Increased legalization of marijuana across North America.
  • Market expansion and emergence of new products and services.
  • Growing recognition of marijuana's pharmaceutical applications.
  • Potential for mergers and acquisitions within the industry.

Amenazas

  • Regulatory changes and uncertainty.
  • Competition from other marijuana-focused ETFs.
  • Market fluctuations and volatility.
  • Negative public perception of marijuana.

Ventajas competitivas

  • Diversified exposure to the marijuana industry reduces risk compared to investing in individual companies.
  • Quarterly rebalancing ensures the portfolio remains aligned with the evolving market landscape.
  • Replication of the North American Marijuana Index provides a benchmark for performance.
  • ETF structure offers liquidity and transparency for investors.

Acerca de HMLSF

Global X Marijuana Life Sciences Index ETF (HMLSF) was created to mirror the performance of the North American Marijuana Index, offering investors a way to tap into the burgeoning marijuana industry without the concentration risk of individual stocks. The fund invests in a basket of North American publicly listed companies that have significant business operations in the marijuana sector. This approach allows investors to gain exposure to the potential upside of the marijuana market while diversifying their risk across multiple companies. The ETF is designed to evolve with the industry. Recognizing the dynamic nature of the marijuana market, HMLSF undergoes quarterly rebalancing. This ensures that the portfolio continues to accurately reflect the composition and performance of the North American Marijuana Index, adapting to the shifting leadership and emerging growth drivers within the sector. The fund's objective is to replicate, as closely as possible, the performance of its benchmark index, net of expenses. This makes it a tool for investors seeking to track the overall performance of the North American marijuana market through a diversified investment vehicle. HMLSF's strategy focuses on providing exposure to companies directly involved in the marijuana industry, from cultivation and retail to pharmaceuticals and related technologies.

Qué hacen

  • Replicates the performance of the North American Marijuana Index.
  • Provides diversified exposure to North American publicly listed companies in the marijuana industry.
  • Offers investors a way to participate in the marijuana market without investing in individual stocks.
  • Rebalances quarterly to reflect the evolving landscape of the marijuana industry.
  • Tracks companies with significant business activities in the marijuana sector.
  • Seeks to minimize expenses while closely mirroring the index's performance.
  • Offers a liquid and transparent way to invest in the marijuana market.

Modelo de Negocio

  • The fund generates revenue through management fees charged to investors.
  • It invests in a basket of North American publicly listed companies involved in the marijuana industry.
  • The fund aims to replicate the performance of the North American Marijuana Index, net of expenses.

Contexto de la Industria

The asset management industry is seeing increased interest in niche ETFs that target specific sectors like the marijuana industry. HMLSF operates within this context, offering a specialized investment product. The marijuana market is characterized by high growth potential, driven by increasing legalization and changing consumer attitudes. However, it also faces regulatory hurdles and competitive pressures. HMLSF competes with other marijuana-focused ETFs and investment vehicles, seeking to attract investors who want exposure to this sector without directly investing in individual companies. The fund's performance is closely tied to the overall growth and stability of the North American marijuana market.

Clientes Clave

  • Retail investors seeking exposure to the marijuana industry.
  • Institutional investors looking for a diversified investment vehicle in the cannabis sector.
  • Investors who want to participate in the growth of the marijuana market without the risk of individual stocks.
Confianza de la IA: 81% Actualizado: 15 mar 2026

Finanzas

Gráfico e información

Precio de la acción de Global X Marijuana Life Sciences Index ETF (HMLSF): Price data unavailable

Últimas noticias

No hay noticias recientes disponibles para HMLSF.

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para HMLSF.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para HMLSF.

MoonshotScore

44/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de HMLSF en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Liderazgo: David Kunselman

Unknown

Information on David Kunselman's background is not available in the provided data. Without additional context, it is impossible to provide details on his career history, education, or previous roles.

Historial: Information on David Kunselman's track record is not available in the provided data. Without additional context, it is impossible to provide details on his key achievements, strategic decisions, or company milestones under his leadership.

Información del mercado OTC de HMLSF

The OTC Other tier, where HMLSF trades, represents the lowest tier of the OTC market. Companies in this tier may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. This often indicates a higher level of risk and less stringent regulatory oversight compared to exchanges like the NYSE or NASDAQ. Investors should be aware that companies in the OTC Other tier may have limited financial disclosure and may be subject to greater price volatility.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: Trading volume for HMLSF on the OTC market is Unknown. This can lead to wider bid-ask spreads and potential difficulty in executing large trades without significantly impacting the price. Investors should exercise caution and consider using limit orders to manage the risk of price slippage. Lower liquidity can also increase price volatility.
Factores de riesgo OTC:
  • Limited financial disclosure due to less stringent reporting requirements.
  • Higher price volatility compared to stocks listed on major exchanges.
  • Potential for wider bid-ask spreads and difficulty in executing large trades.
  • Increased risk of fraud or manipulation due to less regulatory oversight.
  • Lower liquidity can make it difficult to exit positions quickly.
Lista de verificación de diligencia debida:
  • Verify the company's financial statements and disclosures, if available.
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Review the company's legal and regulatory filings.
  • Monitor the company's trading volume and price volatility.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor before investing.
Señales de legitimidad:
  • The fund aims to replicate the performance of the North American Marijuana Index.
  • It provides diversified exposure to North American publicly listed companies in the marijuana industry.
  • The fund is managed by Global X, a well-known ETF provider.

HMLSF Preguntas Frecuentes sobre Acciones de Financial Services

¿Cuáles son los factores clave para evaluar HMLSF?

Global X Marijuana Life Sciences Index ETF (HMLSF) actualmente tiene una puntuación IA de 44/100, indicando puntuación baja. Fortaleza clave: Diversified exposure to the North American marijuana industry.. Riesgo principal a monitorear: Potential: Regulatory uncertainty and changes could negatively impact the marijuana industry.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de HMLSF?

HMLSF actualmente puntúa 44/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de HMLSF?

Los precios de HMLSF se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre HMLSF?

La cobertura de analistas para HMLSF incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en HMLSF?

Las categorías de riesgo para HMLSF incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Regulatory uncertainty and changes could negatively impact the marijuana industry.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de HMLSF?

La relación P/E para HMLSF compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está HMLSF sobrevalorada o infravalorada?

Determinar si Global X Marijuana Life Sciences Index ETF (HMLSF) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de HMLSF?

Global X Marijuana Life Sciences Index ETF (HMLSF) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Information is based on available data and may be subject to change.
  • OTC market data may be less reliable than data from major exchanges.
  • AI analysis is pending and may provide further insights.
Fuentes de datos

Popular Stocks